Application of Arsenic Trioxide-Based Combined Sequential Chemotherapy in Recurrent Resistant and Refractory Ovarian Cancers: A Single-Center, Open Phase II Clinical Study

Table 2

Study drug exposure.

Courses of chemotherapy	No.	%
3	1	3%
4	5	15%
5	2	6%
6	6	18%
7	9	27%
8	2	6%
9	3	9%
10	1	3%
11	2	6%
12	2	6%
Scheme	No	%
1	6	18%
2	27	82%